Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/60027
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhan, Ayad Kareem-
dc.contributor.authorRazik, Basma M Abd-
dc.contributor.authorAmeen, Dina Saleem M-
dc.date.accessioned2022-07-05T10:28:33Z-
dc.date.available2022-07-05T10:28:33Z-
dc.date.issued2022-06-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/60027-
dc.description671-677en_US
dc.description.abstractA new series N-substituted sulfadiazine derivatives attached with different heterocyclic rings such as 4-oxo-1, 4-dihydroquinazolin[7-12], 4-oxo-2H-benzo[1,3]thiazin[13-18] have been synthesized by condensation reactions.The structures of synthesized derivatives are characterized by FT-IR, 1H-NMR, 13C-NMR spectroscopic techniques, andsome physicochemical properties. A molecular docking study is performed and the binding values show very good matchingwith experimentally result. The present work deals with newly synthesized sulfadiazine derivatives that are screened fortheir (In-vitro) antitubercular activity of compounds [7-18] is carried out against Mycobacterium tuberculosis H37Rv.compounds [8,11,13,14,15,17] are found most active (MIC=4-16 μg/mL) and compounds [7, 9,10,12,16,18] are found goodto moderately active (MIC = 62.5-125 μg/mL) by using isoniazid as standard drug.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJC Vol.61(06) [June 2022]en_US
dc.subjectSynthesisen_US
dc.subjectCharacterizationen_US
dc.subjectmolecular dockingen_US
dc.subjectSulfadiazinesen_US
dc.subjectAnti-mycobacterialen_US
dc.titleSynthesis, characterization and molecular docking study of novel N-substituted sulfadiazine derivatives as potential anti-mycobacterial agentsen_US
dc.typeArticleen_US
Appears in Collections:IJC Vol.61(06) [June 2022]

Files in This Item:
File Description SizeFormat 
IJC 61(6) 671-677.pdf957.43 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.